U. Breyer-Pfaff

PURIFICATION AND CHARACTERIZATION OF AKR1B10 FROM HUMAN LIVER: ROLE IN CARBONYL REDUCTION OF XENOBIOTICS

S. Venz, E. Maser, V. Wsól, 2006, Drug Metabolism and Disposition.

Binding of tricyclic antidepressants and perazine to human plasma

U. Breyer-Pfaff, M. Brinkschulte, U. Breyer‐Pfaff, 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.

K. Dietz, U. Breyer-Pfaff, G. Schaber, 1998, British journal of clinical pharmacology.

The contribution of α1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man

U. Breyer-Pfaff, M. Brinkschulte, U. Breyer‐Pfaff, 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

Plasma protein binding of perazine and amitriptyline in psychiatric patients

U. Breyer-Pfaff, M. Brinkschulte, H. Gaertner, 2004, European Journal of Clinical Pharmacology.

Variability of diphenhydramine N-glucuronidation in healthy subjects

U. Breyer-Pfaff, D. Fischer, U. Breyer‐Pfaff, 1997, European Journal of Drug Metabolism and Pharmacokinetics.

Isolation and identification of hydroxylated maprotiline metabolites.

T. Winkler, U. Breyer-Pfaff, M. Kroeker, 1985, Xenobiotica; the fate of foreign compounds in biological systems.

Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver.

E. Maser, M. Ernst, H. Martin, 2004, Drug metabolism and disposition: the biological fate of chemicals.